Patent application number | Description | Published |
20110132261 | System and Method for Depositing a Material on a Substrate - A method and apparatus for depositing a film on a substrate includes introducing a material and a carrier gas into a heated chamber. The material may be a semiconductor material, such as a cadmium chalcogenide. A resulting mixture of vapor and carrier gas containing no unvaporized material is provided. The mixture of vapor and carrier gas are remixed to achieve a uniform vapor/carrier gas composition, which is directed toward a surface of a substrate, such as a glass substrate, where the vapor is deposited as a uniform film. | 06-09-2011 |
20110132262 | System and Method for Depositing a Material on a Substrate - A method and apparatus for depositing a film on a substrate includes introducing a material and a carrier gas into a heated chamber. The material may be a semiconductor material, such as a cadmium chalcogenide. A resulting mixture of vapor and carrier gas containing no unvaporized material is provided. The mixture of vapor and carrier gas are remixed to achieve a uniform vapor/carrier gas composition, which is directed toward a surface of a substrate, such as a glass substrate, where the vapor is deposited as a uniform film. | 06-09-2011 |
20110132263 | System and Method for Depositing a Material on a Substrate - A method and apparatus for depositing a film on a substrate includes introducing a material and a carrier gas into a heated chamber. The material may be a semiconductor material, such as a cadmium chalcogenide. A resulting mixture of vapor and carrier gas containing no unvaporized material is provided. The mixture of vapor and carrier gas are remixed to achieve a uniform vapor/carrier gas composition, which is directed toward a surface of a substrate, such as a glass substrate, where the vapor is deposited as a uniform film. | 06-09-2011 |
20110211920 | MATERIAL SUPPLY SYSTEM AND METHOD - A system and a method for feeding a solid into a solid deposition system is described. Solid contained in a hopper is directed into a vibratory bowl. The frequency of the vibrations of the vibratory bowl can be modulated by a feedback system. The solid can then be entrained in a carrier gas which can flow to a distributor for deposition on a substrate. | 09-01-2011 |
20110232570 | SYSTEM AND METHOD FOR DEPOSITING A MATERIAL ON A SUBSTRATE - A method and apparatus for depositing a film on a substrate includes introducing a material and a carrier gas into a heated chamber. The material may be a semiconductor material, such as a cadmium chalcogenide. A resulting mixture of vapor and carrier gas containing no unvaporized material is provided. The mixture of vapor and carrier gas are remixed to achieve a uniform vapor/carrier gas composition, which is directed toward a surface of a substrate, such as a glass substrate, where the vapor is deposited as a uniform film. | 09-29-2011 |
20130019953 | SYSTEM AND METHOD FOR DEPOSITING A MATERIAL ON A SUBSTRATE - A method and apparatus for depositing a film on a substrate includes introducing a material and a carrier gas into a heated chamber. The material may be a semiconductor material, such as a cadmium chalcogenide. A resulting mixture of vapor and carrier gas containing no unvaporized material is provided. The mixture of vapor and carrier gas are remixed to achieve a uniform vapor/carrier gas composition, which is directed toward a surface of a substrate, such as a glass substrate, where the vapor is deposited as a uniform film. | 01-24-2013 |
Patent application number | Description | Published |
20150369013 | SYSTEMS AND METHODS FOR CLOUD-BASED AUTOMATIC CONFIGURATION OF REMOTE TERMINAL UNITS - A remote terminal unit (RTU) may control one or more operations a well device associated with a hydrocarbon well. The RTU may include a processor that may broadcast a request to communicatively couple to a cloud-computing system. The processor may then receive a confirmation from the cloud-computing system indicating that the RTU has successfully communicatively coupled to the cloud-computing system and send one or more attributes regarding the RTU, the well device, the hydrocarbon well, or any combination thereof to the cloud-computing system. The processor may then receive one or more software packages from the cloud-computing system based on the attributes. Using the software packages, the processor may control the operations of the well device. | 12-24-2015 |
20150369014 | SYSTEMS AND METHODS FOR CLOUD-BASED COMMISSIONING OF WELL DEVICES - A method may include receiving, via at least one processor of a cloud-computing system, an indication that a portion of a workflow is complete. Here, the workflow is associated with commissioning one or more well devices at a hydrocarbon site. The method may then include identifying one or more subsequent portions of the workflow to be performed and sending the one or more subsequent portions to one or more computing devices associated with one or more users assigned to the one or more well devices. | 12-24-2015 |
20150371160 | SYSTEMS AND METHODS FOR CLOUD-BASED ASSET MANAGEMENT AND ANALYSIS REGARDING WELL DEVICES - A method for a cloud-computing system to communicatively couple with a remote terminal unit (RTU) that monitors and/or controls one or more operations a well device associated with a hydrocarbon well may include receiving, via at least one processor, a request from an asset attempting to communicatively couple with the cloud-computing system. The method may then include determining whether the asset is known and receiving one or more attributes regarding the asset when the asset is not known. After receiving the attributes, the method may include determining whether a profile that corresponds to the one or more attributes exists and sending configuration data to the asset based on the profile when the profile exists. | 12-24-2015 |
Patent application number | Description | Published |
20100016336 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-21-2010 |
20100069448 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-18-2010 |
20120077853 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
20120077975 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHOD OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
20130023542 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-24-2013 |
20130023543 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-24-2013 |
20130096140 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 04-18-2013 |
20130324558 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 12-05-2013 |
20140221666 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 08-07-2014 |
20150210656 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 07-30-2015 |
Patent application number | Description | Published |
20100129833 | Methods to Identify Modulators - Sucralose-binding TAS2R bitter taste receptors have been identified. Novel methods to identify modulators and in particular inhibitors to the bitter taste of sucralose and an inhibitor, are provided. | 05-27-2010 |
20100178389 | Consumables - Disclosed are sweetened consumables and methods of forming said sweetened consumables that comprise certain sweeteners and a compound of formula (1), wherein R | 07-15-2010 |
20100284944 | OFF-NOTE BLOCKING SENSORY ORGANIC COMPOUNDS - Disclosed are Compounds that block off-notes in consumables and methods of blocking off-notes in consumables including off-notes provided by artificial sweeteners including aspartame, Saccharin, acesulfame K (Acesulfame potassium), sucralose and cyclamate; and including stevioside, swingle extract, glyccerhizin, perillartine, naringin dihydrochalcone, neohesperidine dihydrochalcone, mogroside V, rubusoside, rubus extract, and rebaudioside A. | 11-11-2010 |
20100311786 | MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS - Disclosed are compounds that block off-notes in consumables and methods of blocking off-notes in consumables including off-notes provided by sweeteners such as stevioside, swingle extract, glyccerhizin, perillartine, naringin dihydrochalcone, neohesperidine dihydrochalcone, mogroside V, rubusoside, rubus extract, and rebaudioside A, and artificial sweeteners such as aspartame, saccharin, acesulfame K (Acesulfame potassium), sucralose and cyclamate. | 12-09-2010 |
20110086138 | Bitter Alkaloid Containing Consumables Comprising Bitter Blockers - Disclosed are bitter alkaloid-containing consumables comprising bitter blockers for a reduced alkaloid-derived bitterness and methods of forming said consumables. | 04-14-2011 |
20120196018 | Organic Compounds - An orally-administrable product comprising an ingredient or ingredients that have associated with their use an unacceptable aftertaste, and a cooling compound employed as a taste-masking agent in an amount of 0.5 ppm or less. | 08-02-2012 |
20120244271 | AFTERTASTE MASKING - A method of masking a bitter aftertaste experienced in the consumption of a consumable composition, including the addition to the composition of a masking quantity of choline chloride. The proportion required is considerably less than the proportion of choline chloride used as a dietary supplement. | 09-27-2012 |
20140005153 | Off-Note Masking | 01-02-2014 |
20140194651 | OFF-NOTE BLOCKING SENSORY ORGANIC COMPOUNDS - Disclosed are compounds that block off-notes in consumables and methods of blocking off-notes in consumables including off-notes provided by artificial sweeteners including aspartame, saccharin, acesulfame K (Acesulfame potassium), sucralose and cyclamate; and including stevioside, swingle extract, glyccerhizin, perillartine, naringin dihydrochalcone, neohesperidine dihydrochalcone, mogroside V, rubusoside, rubus extract, and rebaudioside A. | 07-10-2014 |
20140242255 | Consumables - Disclosed are sweetened consumables and methods of forming said sweetened consumables that comprise certain sweeteners and a compound of formula (1), | 08-28-2014 |
20140370177 | COMPOSITIONS - A mixture of the individual ingredients stevioside and rebaudioside A provided in a ratio of stevioside to rebaudioside A of about 1:1 to about 4:1. | 12-18-2014 |
20150313265 | Consumables - Disclosed are sweetened consumables and methods of forming said sweetened consumables that comprise certain sweeteners and a compound of formula (1), | 11-05-2015 |
Patent application number | Description | Published |
20080311266 | Salt Enhancement - A method of enhancing the perceived saltiness of an orally-ingestible composition, comprising the incorporation therein of a compound which is a cooling compound in a proportion that is below the cooling threshold but that provides a salt enhancement. Therefore, less salt is needed to provide, a desirable salty taste to foodstuffs, beverages and the like, and the products, are healthier as a result. | 12-18-2008 |
20090104320 | Stabilization of Milk-Based Products - Dairy-derived food products, particularly beverages, such as milk/juice blends, yogurt-based drinks, fermented milk beverages, and soft drinks, are disclosed. These compositions contain a stabilizing mixture comprising metal (in the form of ions, salts or oxides) such as zinc or magnesium, either alone or together with an adjunct component such as ascorbic acid. These beverage products do not form off-flavors when they are exposed to sunlight or fluorescent light. This provides for more efficient and inexpensive manufacture of the products and eliminates the need for expensive opaque packing materials. | 04-23-2009 |
Patent application number | Description | Published |
20100064299 | Deployment and Management of Virtual Containers - A system virtualizes applications on a managed endpoint using containers. A managed endpoint receives a virtualized container from an IT automation appliance. The virtualized container includes an application and a virtualization module. The virtualization module includes computer program instructions for virtualizing the application. An operating system API call made by the application during execution is intercepted, and a portion of the computer program instructions are executed based on the operating system API call. The computer program instructions modify the behavior of the application to effect the file and data virtualization of the application. A virtualized container can be deployed and updated from an IT automation appliance along with an agent to support the deployment and updating of the virtualized container. | 03-11-2010 |
20120259900 | Virtual Disk Utility - In particular embodiments, a method comprising, by one or more computing devices, installing an application on a portion of a physical disk system of a first platform, virtualizing the portion of the physical disk system into a virtual disk system, comprising, storing data in the portion of the physical disk system in a database of the virtual disk system, providing an interface to access the data stored in the database, and providing a plurality sets of drivers for a plurality of platforms, wherein each set of drivers supports native operations with respect to the portion of the physical disk system on a different one of the plurality of platforms, mounting the virtual disk system on a second platform, and executing the application on the second platform, wherein all operations in connection with executing the application are contained within the virtual disk system mounted on the second platform. | 10-11-2012 |
20120259981 | Hypercasting - In one embodiment, a method comprises, in response to data to be distributed to a second computing device, selecting, by a first computing device, at least one third computing device for the second computing device, wherein each of the at least one third computing device has at least a portion of a copy of the data; and notifying, by the first computing device, the second computing device information concerning each of the at least one third computing device in order for the second computing device to obtain a copy of the data from the at least one third computing device. | 10-11-2012 |
20130179500 | Home Hub - In one embodiment, transmitting, from a first computing device, a private-home-network-discovery message that comprises a first identifier corresponding to a private-home-networking system, receiving, at the first computing device, one or more content-response messages from a second computing device that collectively comprise a second identifier corresponding to the second computing device, a third identifier corresponding to the private-home-networking system, and information corresponding to content stored on the second computing device, and storing, at the first computing device, the second and third identifiers and the information received in the one or more content response messages for access by one or more applications hosted on the first computing device, one of the applications being associated with administering the private-home-networking system. | 07-11-2013 |
Patent application number | Description | Published |
20100227132 | POLYURETHANE BASED RIGID FLOORING LAMINATE - The laminate according to the invention is a multiple layer structure and contains predominantly urethane-based polymeric materials in the cap and base layers thereof, with no significant amount of PVC. As such, under combustion conditions, the laminate releases substantially no harmful halogen-based bases, such as HCl or other toxic gases, and exhibits toxicity and smoke generation parameters well below acceptable industry standards. | 09-09-2010 |
20100272976 | DECORATIVE LAMINATES INCORPORATING FLAME RETARDANT ENGINEERING THERMOPLASTIC FILMS - A decorative laminate that contains at least three layers that include a surface layer, a backing layer and a color layer positioned between the surface and backing layers. The surface layer or backing layer or both are made of flame retardant engineering thermoplastic materials. | 10-28-2010 |
20120009427 | SOLVENT CAST FLAME RETARDANT POLYCARBONATE COATINGS, FILMS AND LAMINATES - Solvent cast polycarbonate-based films for use in laminates with flame retardance, low heat release and low smoke production, and methods of manufacture. Polycarbonate resin or polymer blends of polycarbonate resin and one or more polymer resins are solvent cast and incorporated into decorative, fire retardant and protective laminates. | 01-12-2012 |
20130129567 | SYSTEM AND METHOD FOR GENERATION OF ACTIVE SPECIES IN A MEDIA BY UV RADIATION - A system for sanitizing an article includes an ultraviolet light emitting a frequency of light anywhere between 122-230 nm projected toward the article. A medium dispersed about the article and intersecting with the projected ultraviolet light is also provided. The medium interacts with the frequency of light to generate reactive oxygen species that eliminate microbes on the article. Specific light frequencies may be used in combination with different mediums. | 05-23-2013 |
20130175296 | PEROXIDE POWERED PRODUCT DISPENSING SYSTEM - A dispensing system includes a decomposition chamber having a catalyst for the decomposition of hydrogen peroxide. The hydrogen peroxide and a foaming soap are provided in separate first and second chambers of a product reservoir portion of a refill unit. Decomposition of the hydrogen peroxide produces oxygen gas and water, that may be used as a propellant for the creation of the foamed product, or may be used to power a pump. Additionally, the oxygen gas may be used to power a scavenger for the creation of electricity for charging a battery within the dispenser. | 07-11-2013 |
20140271354 | METHODS AND SOLUTIONS FOR KILLING OR DEACTIVATING BACTERIA - Exemplary methods for killing or deactivating bacteria are provided herein. One exemplary method includes providing a plasma system and a filter below the plasma system. Energizing the plasma generator to create indirect plasma downstream of the filter and activating a fluid with the indirect plasma and applying the activated fluid to bacteria is shown to deactivate and kill bacteria. | 09-18-2014 |
20150094647 | METHODS AND APPARATUS FOR DELIVERY OF MOLECULES ACROSS LAYERS OF TISSUE - Exemplary methods of opening pores and moving molecules into tissue comprising, applying plasma to the surface of tissue and applying a carrier including one or more molecules to the surface of the tissue are disclosed herein. | 04-02-2015 |
20150102053 | PEROXIDE POWERED PRODUCT DISPENSING SYSTEM - A dispensing system includes a decomposition chamber having a catalyst for the decomposition of hydrogen peroxide. The hydrogen peroxide and a foaming soap are provided in separate first and second chambers of a product reservoir portion of a refill unit. Decomposition of the hydrogen peroxide produces oxygen gas and water that may be used as a propellant for the creation of the foamed product, or may be used to power a pump. Additionally, the oxygen gas may be used to power a scavenger for the creation of electricity for charging a battery within the dispenser. | 04-16-2015 |
20150151135 | TRANSDERMAL DELIVERY OF DNA VACCINES USING NON-THERMAL PLASMA - Exemplary systems and methods of delivering DNA vaccines are disclosed herein. An exemplary methodology of delivering DNA vaccines includes providing a plasma generator for applying plasma to a treatment area for a sufficient period of time to open one or more pores. Applying a topical DNA vaccine to the treatment area and waiting for a period of time to allow the DNA vaccine to travel through the one or more pores. The exemplary methodology further includes applying plasma to the treatment area at a setting sufficient to cause intracellular uptake of the DNA vaccine. | 06-04-2015 |
20150157870 | SHAPE CONFORMING FLEXIBLE DIELECTRIC BARRIER DISCHARGE PLASMA GENERATORS - Exemplary embodiments of shape conforming dielectric barrier discharge (DBD) plasma generators are disclosed herein. One exemplary embodiment includes a flexible pad and a plurality of electrodes located in the pad within close proximity of each other, and a flexible dielectric barrier surrounding the plurality of electrodes and separating the plurality of electrodes from each other. Wherein when a high voltage pulse is applied to one or more of the plurality of electrodes, plasma is produced between a surface of the flexible pad and a portion of the body in close proximity to the flexible pad. | 06-11-2015 |
20150209595 | METHOD AND APPARATUS FOR INTRACELLULAR AND INTERCELLULAR DELIVERY OF MOLECULES, DRUGS, VACCINES AND THE LIKE - An exemplary method of delivering drugs or vaccines includes applying a series of first electrical signals to an electrode to generate plasma. The first electrical pulses having a first duration, first voltage amplitude, and first rise time. Applying molecules, drugs or vaccines to an area of skin contacted by the plasma; and applying a series of second electrical signals to the electrode to generate plasma to contact the area of the skin. The second electrical pulses have a second duration, second voltage amplitude, and second rise time. The duration for the first electrical pulses is shorter than the duration for the second electrical pulses. The voltage amplitude of the second electrical pulses is larger than the first electrical pulses. The rise time of the second electrical pulses is shorter than the first electrical pulses. | 07-30-2015 |
20150265736 | METHODS AND SOLUTIONS FOR KILLING OR DEACTIVATING SPORES - Exemplary methods and systems for killing or deactivating spores include applying a fluid to a surface containing a spore; and applying direct or indirect plasma to the surface for a period of time. In some embodiments, the fluid includes water. In some embodiments, the spore is | 09-24-2015 |
20150306258 | PLASMA STERILIZATION OF CORNEAL TISSUE - Exemplary methods of treating tissue that has been harvested for transplant are disclosed herein. An exemplary method of preparing corneal tissue for transplant includes obtaining corneal tissue that has been harvested for transplanting and exposing the corneal tissue to a plasma-activated fluid for a period of time. | 10-29-2015 |
20150373923 | TREATED SPROUT PLANTS WITH DECREASED BACTERIAL VIABILITY AND METHODS AND APPARATUSES FOR MAKING THE SAME - Plasma treatment devices for reducing bacterial viability, enhancing stem growth, enhancing root growth or increasing germination times are disclosed herein. In addition, a treated sprout plant treated with a plasma activate medium or plasma with decreased bacterial viability relative to an untreated sprout plant. The treated sprout plant has at least a 1-log reduction in bacterial viability relative to the untreated sprout plant. Methods and apparatuses of producing the treated sprout plant are also provided. | 12-31-2015 |
20160022850 | METHODS AND SOLUTIONS FOR RAPIDLY KILLING OR DEACTIVATING SPORES - Exemplary methods and systems for killing or deactivating spores include applying a fluid to a surface containing a spore; and applying direct or indirect plasma to the surface for a period of time. In some embodiments, the fluid includes water. In some embodiments, the spore is | 01-28-2016 |